Atlas Trials

2003

5,672 clinical trials · Start year

Sort:Newest firstOldest first

◉ Watch 2003

RecordFirmDate
Fatty Acids, Genes and Microbiota in Fatty Liver (NCT02148471)Johane Allard2003-10-01
Infliximab in Treating Patients With Myelodysplastic Syndrome (NCT00074074)European Organisation for Research and Treatment of Cancer - EORTC2003-10-01
Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males (NCT00594581)Renovo2003-10-01
Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression (NCT00426192)University Hospital, Saarland2003-10-01
Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. (NCT00225264)Takeda2003-10-01
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma (NCT00077584)Actelion2003-10-01
Palliative Strategies in Spinal Cord Injury (SCI) (NCT00594178)University of Arkansas2003-10-01
Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer (NCT00500435)M.D. Anderson Cancer Center2003-10-01
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer (NCT00090610)Duke University2003-10-01
Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men (NCT00365729)Deutsche Luft und Raumfahrt2003-10-01
Transitioning From Cyclosporine to Alefacept in Psoriasis (NCT00143806)University of Medicine and Dentistry of New Jersey2003-10-01
A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies (NCT00338143)Genentech, Inc.2003-10-01
Endoscopic Implantation of Enteryx for the Treatment of GERD (NCT00346905)Beth Israel Deaconess Medical Center2003-10-01
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline (NCT00143299)Pfizer2003-10-01
Allogenic Islet Cell Transplantation (NCT00160732)University of Chicago2003-10-01
Changes in Cerebral Oxygenation During Deliberate Hypotensive Anesthesia (NCT00207987)China Medical University Hospital2003-10-01
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy (NCT00188214)University Health Network, Toronto2003-10-01
A Transtheoretical Model Group Therapy for Cocaine (NCT00178776)National Institute on Drug Abuse (NIDA)2003-10-01
Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML) (NCT01723657)Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias2003-10-01
Evaluating the Effectiveness of a Community Based Intervention for Persons With Dementia and Their Caregivers in a Developing Country (NCT00479271)London School of Hygiene and Tropical Medicine2003-10-01
Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population. (NCT00307008)GlaxoSmithKline2003-10-01
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00075478)Fred Hutchinson Cancer Center2003-10-01
Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) (NCT00079482)Cephalon2003-10-01
Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients (NCT00284531)Baylor College of Medicine2003-10-01
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) (NCT00951574)Italfarmaco2003-10-01
Trial of Ropinirole in Motor Recovery After Stroke (NCT00221390)University of California, Irvine2003-10-01
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes (NCT00206297)Baylor College of Medicine2003-10-01
Cognition, Functioning and Quality of Life (NCT00182442)Hamilton Health Sciences Corporation2003-10-01
Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes (NCT00071422)Exsulin Corporation2003-10-01
Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes (NCT00071409)Exsulin Corporation2003-10-01
Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study) (NCT00247715)Radboud University Medical Center2003-10-01
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150)National Cancer Institute (NCI)2003-10-01
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer (NCT00071942)National Cancer Institute (NCI)2003-10-01
Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population (NCT00259077)AstraZeneca2003-10-01
Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient Management (NCT01520168)University of Wuerzburg2003-10-01
ABC Trial: Awakening and Breathing Controlled (NCT00097630)National Institute on Aging (NIA)2003-10-01
Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia (NCT00088049)Eli Lilly and Company2003-10-01
An Electronic Pillbox for People With HIV (NCT00071500)National Institute of Allergy and Infectious Diseases (NIAID)2003-10-01
Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas (NCT01538641)Auxilio Mutuo Cancer Center2003-10-01
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors (NCT00125827)Genzyme, a Sanofi Company2003-10-01
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma (NCT00193505)SCRI Development Innovations, LLC2003-10-01
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) (NCT00071487)Human Genome Sciences Inc.2003-10-01
Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00074204)Case Comprehensive Cancer Center2003-10-01
Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers (NCT00651586)Allergan2003-10-01
Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability (NCT00242177)University of Illinois at Chicago2003-10-01
Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF) (NCT00288587)NxStage Medical2003-10-01
Interaction Between Cocaine and Quetiapine - 1 (NCT00087750)National Institute on Drug Abuse (NIDA)2003-10-01
Effect of C-Peptide on Diabetic Peripheral Neuropathy (NCT00278980)Creative Peptides Sweden Inc.2003-10-01
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs). (NCT00576017)Janssen-Cilag, S.A.2003-10-01
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer (NCT00113789)Amgen2003-10-01
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases (NCT00068068)Light Sciences LLC2003-10-01
ISTAPS: A Stepped Primary Care Smoking Cessation Intervention (NCT00125905)Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina2003-10-01
Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease (NCT00191009)Eli Lilly and Company2003-10-01
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1 (NCT00078143)University of Cincinnati2003-10-01
PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia (NCT00362544)Gilead Sciences2003-10-01
Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma (NCT01296503)Grupo de Estudos Multicentricos em Onco-Hematologia2003-10-01
The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients (NCT00289003)Biotec Pharmacon ASA2003-10-01
MVCT Imaging Pilot Study Using Helical Tomotherapy (NCT00168142)AHS Cancer Control Alberta2003-10-01
Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State (NCT00647738)Mylan Pharmaceuticals Inc2003-10-01
A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection (NCT00177346)University of Pittsburgh2003-10-01
Study of CBME in the Relief of Painful Diabetic Neuropathy (NCT00238550)Sheffield Teaching Hospitals NHS Foundation Trust2003-10-01
Pilot Study of the Efficacy & Safety of Natural Eggshell Membrane (NEM) for Joint & Connective Tissue Disorders (NCT00750230)ESM Technologies, LLC2003-10-01
Complications After Epilepsy Surgery (NCT04727892)First Affiliated Hospital Xi'an Jiaotong University2003-10-01
A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer (NCT00164931)Chinese University of Hong Kong2003-10-01
Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00055757)National Cancer Institute (NCI)2003-10-01
Evaluation of Resynchronization Therapy for Heart Failure (EARTH) (NCT00901212)Montreal Heart Institute2003-10-01
Uremic Toxins of Patients With Acute Kidney Failure (NCT00148044)University Hospital, Ghent2003-10-01
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (NCT00124709)Novartis Pharmaceuticals2003-10-01
Once Daily Given Alfuzosin in the Treatment of BPH (NCT00637715)Sanofi2003-10-01
Prophylaxis With Caspofungin in High-Risk Liver Transplantation (NCT00333645)Grupo de Estudio de Infecciones en Transplantados2003-10-01
A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery (NCT00404391)Abbott2003-10-01
The Verona Newly Diagnosed Type 2 Diabetes Study (NCT01526720)Universita di Verona2003-10-01
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ (NCT00772928)Sanofi2003-10-01
A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department (NCT00429832)University of New Mexico2003-10-01
Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) (NCT00074529)Merck Sharp & Dohme LLC2003-10-01
A Study of Infliximab in Patients With Sarcoidosis (NCT00073437)Centocor, Inc.2003-10-01
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer (NCT00068601)SWOG Cancer Research Network2003-10-01
Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function (NCT01740362)Pfizer2003-10-01
CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis (NCT00631254)Laval University2003-10-01
MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer (NCT00070837)Millennium Pharmaceuticals, Inc.2003-10-01
ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) (NCT00208299)Gilead Sciences2003-10-01
Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) (NCT00542178)National Heart, Lung, and Blood Institute (NHLBI)2003-10-01
Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg (NCT00649376)Mylan Pharmaceuticals Inc2003-10-01
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (NCT00071890)National Institute of Allergy and Infectious Diseases (NIAID)2003-10-01
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women (NCT03822078)Amgen2003-09-30
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). (NCT00352963)GlaxoSmithKline2003-09-30
Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis (NCT00503243)Shire2003-09-30
Genetic Analysis of Gray Platelet Syndrome (NCT00069680)National Human Genome Research Institute (NHGRI)2003-09-29
Influence of Age and Sex on Alcohol Metabolism and Acute Responses (NCT00070577)National Institute on Alcohol Abuse and Alcoholism (NIAAA)2003-09-29
Evaluation of Chronic Orthostatic Intolerance (NCT00069693)National Institute of Neurological Disorders and Stroke (NINDS)2003-09-26
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) (NCT00090155)Merck Sharp & Dohme LLC2003-09-26
Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage (NCT05098236)University of Rochester2003-09-26
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease (NCT00069654)National Heart, Lung, and Blood Institute (NHLBI)2003-09-25
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) (NCT00092066)Organon and Co2003-09-24
Seasonal Affective Depression (SAD) Study (NCT00069459)GlaxoSmithKline2003-09-23
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases (NCT00069342)National Institutes of Health Clinical Center (CC)2003-09-22
Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease (NCT00069316)National Institutes of Health Clinical Center (CC)2003-09-22
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients (NCT00129389)Spanish Breast Cancer Research Group2003-09-19
Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas (NCT00069238)National Cancer Institute (NCI)2003-09-19
Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) (NCT01855711)GlaxoSmithKline2003-09-18
← Previous Next →

Track 2003 automatically

Every clearance here is in the API, with alerts when new ones post.